Light Mode
$4.01 ↓ -0.01 (-0.20%) Trading Down from the previous close of $4.02
-1.16 (-22.39%) / 6M
Momentum, market sentiment, and recent alerts
ZURA reads not so good: price sits above one of the two key moving averages, the 12-month move is +10.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Zura Bio Ltd. is a clinical-stage, multi-asset immunology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.